299 related articles for article (PubMed ID: 22936179)
1. A potential role for dendritic cell/macrophage-expressing DPP4 in obesity-induced visceral inflammation.
Zhong J; Rao X; Deiuliis J; Braunstein Z; Narula V; Hazey J; Mikami D; Needleman B; Satoskar AR; Rajagopalan S
Diabetes; 2013 Jan; 62(1):149-57. PubMed ID: 22936179
[TBL] [Abstract][Full Text] [Related]
2. Hepatocyte-secreted DPP4 in obesity promotes adipose inflammation and insulin resistance.
Ghorpade DS; Ozcan L; Zheng Z; Nicoloro SM; Shen Y; Chen E; Blüher M; Czech MP; Tabas I
Nature; 2018 Mar; 555(7698):673-677. PubMed ID: 29562231
[TBL] [Abstract][Full Text] [Related]
3. An emerging role of dipeptidyl peptidase 4 (DPP4) beyond glucose control: potential implications in cardiovascular disease.
Zhong J; Rao X; Rajagopalan S
Atherosclerosis; 2013 Feb; 226(2):305-14. PubMed ID: 23083681
[TBL] [Abstract][Full Text] [Related]
4. Circulating Levels of Soluble Dipeptidyl Peptidase-4 Are Dissociated from Inflammation and Induced by Enzymatic DPP4 Inhibition.
Varin EM; Mulvihill EE; Beaudry JL; Pujadas G; Fuchs S; Tanti JF; Fazio S; Kaur K; Cao X; Baggio LL; Matthews D; Campbell JE; Drucker DJ
Cell Metab; 2019 Feb; 29(2):320-334.e5. PubMed ID: 30393019
[TBL] [Abstract][Full Text] [Related]
5. DPP4 inhibition mitigates ANG II-mediated kidney immune activation and injury in male mice.
Nistala R; Meuth AI; Smith C; An J; Habibi J; Hayden MR; Johnson M; Aroor A; Whaley-Connell A; Sowers JR; McKarns SC; Bender SB
Am J Physiol Renal Physiol; 2021 Mar; 320(3):F505-F517. PubMed ID: 33522410
[TBL] [Abstract][Full Text] [Related]
6. Oxidized LDL upregulates macrophage DPP4 expression via TLR4/TRIF/CD36 pathways.
Rao X; Zhao S; Braunstein Z; Mao H; Razavi M; Duan L; Wei Y; Toomey AC; Rajagopalan S; Zhong J
EBioMedicine; 2019 Mar; 41():50-61. PubMed ID: 30738832
[TBL] [Abstract][Full Text] [Related]
7. Prevention of obesity-induced renal injury in male mice by DPP4 inhibition.
Nistala R; Habibi J; Lastra G; Manrique C; Aroor AR; Hayden MR; Garro M; Meuth A; Johnson M; Whaley-Connell A; Sowers JR
Endocrinology; 2014 Jun; 155(6):2266-76. PubMed ID: 24712875
[TBL] [Abstract][Full Text] [Related]
8. Unravelling the immunological roles of dipeptidyl peptidase 4 (DPP4) activity and/or structure homologue (DASH) proteins.
Wagner L; Klemann C; Stephan M; von Hörsten S
Clin Exp Immunol; 2016 Jun; 184(3):265-83. PubMed ID: 26671446
[TBL] [Abstract][Full Text] [Related]
9. A novel multi-epitope vaccine based on Dipeptidyl Peptidase 4 prevents streptozotocin-induced diabetes by producing anti-DPP4 antibody and immunomodulatory effect in C57BL/6J mice.
Li Z; Fang J; Jiao R; Wei X; Ma Y; Liu X; Cheng P; Li T
Biomed Pharmacother; 2017 May; 89():1467-1475. PubMed ID: 28376584
[TBL] [Abstract][Full Text] [Related]
10. DPP4 inhibition by sitagliptin attenuates LPS-induced lung injury in mice.
Kawasaki T; Chen W; Htwe YM; Tatsumi K; Dudek SM
Am J Physiol Lung Cell Mol Physiol; 2018 Nov; 315(5):L834-L845. PubMed ID: 30188745
[TBL] [Abstract][Full Text] [Related]
11. Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome.
Lamers D; Famulla S; Wronkowitz N; Hartwig S; Lehr S; Ouwens DM; Eckardt K; Kaufman JM; Ryden M; Müller S; Hanisch FG; Ruige J; Arner P; Sell H; Eckel J
Diabetes; 2011 Jul; 60(7):1917-25. PubMed ID: 21593202
[TBL] [Abstract][Full Text] [Related]
12. Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system.
Klemann C; Wagner L; Stephan M; von Hörsten S
Clin Exp Immunol; 2016 Jul; 185(1):1-21. PubMed ID: 26919392
[TBL] [Abstract][Full Text] [Related]
13. Beneficial Effects of Evogliptin, a Novel Dipeptidyl Peptidase 4 Inhibitor, on Adiposity with Increased Ppargc1a in White Adipose Tissue in Obese Mice.
Chae YN; Kim TH; Kim MK; Shin CY; Jung IH; Sohn YS; Son MH
PLoS One; 2015; 10(12):e0144064. PubMed ID: 26633898
[TBL] [Abstract][Full Text] [Related]
14. An interaction between glucagon-like peptide-1 and adenosine contributes to cardioprotection of a dipeptidyl peptidase 4 inhibitor from myocardial ischemia-reperfusion injury.
Ihara M; Asanuma H; Yamazaki S; Kato H; Asano Y; Shinozaki Y; Mori H; Minamino T; Asakura M; Sugimachi M; Mochizuki N; Kitakaze M
Am J Physiol Heart Circ Physiol; 2015 May; 308(10):H1287-97. PubMed ID: 25747753
[TBL] [Abstract][Full Text] [Related]
15. Emerging Role of Dipeptidyl Peptidase-4 in Autoimmune Disease.
Huang J; Liu X; Wei Y; Li X; Gao S; Dong L; Rao X; Zhong J
Front Immunol; 2022; 13():830863. PubMed ID: 35309368
[TBL] [Abstract][Full Text] [Related]
16. Diabetes, hypertension, and chronic kidney disease progression: role of DPP4.
Nistala R; Savin V
Am J Physiol Renal Physiol; 2017 Apr; 312(4):F661-F670. PubMed ID: 28122713
[TBL] [Abstract][Full Text] [Related]
17. The CD26/DPP4-inhibitor vildagliptin suppresses lung cancer growth via macrophage-mediated NK cell activity.
Jang JH; Janker F; De Meester I; Arni S; Borgeaud N; Yamada Y; Gil Bazo I; Weder W; Jungraithmayr W
Carcinogenesis; 2019 Apr; 40(2):324-334. PubMed ID: 30698677
[TBL] [Abstract][Full Text] [Related]
18. Dipeptidyl peptidase-4 inhibition prevents lung injury in mice under chronic stress via the modulation of oxidative stress and inflammation.
Zhang S; Li P; Xin M; Jin X; Zhao L; Nan Y; Cheng XW
Exp Anim; 2021 Nov; 70(4):541-552. PubMed ID: 34219073
[TBL] [Abstract][Full Text] [Related]
19. Middle east respiratory syndrome corona virus spike glycoprotein suppresses macrophage responses via DPP4-mediated induction of IRAK-M and PPARγ.
Al-Qahtani AA; Lyroni K; Aznaourova M; Tseliou M; Al-Anazi MR; Al-Ahdal MN; Alkahtani S; Sourvinos G; Tsatsanis C
Oncotarget; 2017 Feb; 8(6):9053-9066. PubMed ID: 28118607
[TBL] [Abstract][Full Text] [Related]
20. Dipeptidyl peptidase IV (DPP4)-deficiency attenuates diet-induced obesity in rats: possible implications for the hypothalamic neuropeptidergic system.
Stephan M; Radicke A; Leutloff S; Schmiedl A; Pabst R; von Hörsten S; Dettmer S; Lotz J; Nave H
Behav Brain Res; 2011 Jan; 216(2):712-8. PubMed ID: 20887754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
